DK267689A - Ikke-beta-oxiderbare fede syrer analoge med blodcholesterol- og -triglyceridsaenkende evne og praeparater indeholdende saadanne forbindelser - Google Patents

Ikke-beta-oxiderbare fede syrer analoge med blodcholesterol- og -triglyceridsaenkende evne og praeparater indeholdende saadanne forbindelser Download PDF

Info

Publication number
DK267689A
DK267689A DK267689A DK267689A DK267689A DK 267689 A DK267689 A DK 267689A DK 267689 A DK267689 A DK 267689A DK 267689 A DK267689 A DK 267689A DK 267689 A DK267689 A DK 267689A
Authority
DK
Denmark
Prior art keywords
compounds
triglyceride
beta
preparations containing
blood cholesterol
Prior art date
Application number
DK267689A
Other languages
English (en)
Other versions
DK267689D0 (da
Inventor
Rolf K Berge
Jon Bremer
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Publication of DK267689D0 publication Critical patent/DK267689D0/da
Publication of DK267689A publication Critical patent/DK267689A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK267689A 1988-06-02 1989-06-01 Ikke-beta-oxiderbare fede syrer analoge med blodcholesterol- og -triglyceridsaenkende evne og praeparater indeholdende saadanne forbindelser DK267689A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888813012A GB8813012D0 (en) 1988-06-02 1988-06-02 Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals

Publications (2)

Publication Number Publication Date
DK267689D0 DK267689D0 (da) 1989-06-01
DK267689A true DK267689A (da) 1989-12-03

Family

ID=10637920

Family Applications (1)

Application Number Title Priority Date Filing Date
DK267689A DK267689A (da) 1988-06-02 1989-06-01 Ikke-beta-oxiderbare fede syrer analoge med blodcholesterol- og -triglyceridsaenkende evne og praeparater indeholdende saadanne forbindelser

Country Status (8)

Country Link
US (1) US5093365A (da)
EP (1) EP0345038B1 (da)
AT (1) ATE96664T1 (da)
CA (1) CA1329550C (da)
DE (1) DE68910386T2 (da)
DK (1) DK267689A (da)
ES (1) ES2059749T3 (da)
GB (1) GB8813012D0 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996011908A1 (en) * 1994-10-13 1996-04-25 Peptide Technology Limited Modified polyunsaturated fatty acids
NO952796D0 (no) * 1995-07-14 1995-07-14 Rolf Berge Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater
WO1999058120A1 (en) * 1998-05-08 1999-11-18 Rolf Berge USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
US20020074691A1 (en) * 1999-09-14 2002-06-20 Robert M Mortellite High speed method of making plastic film and nonwoven laminates
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
NO328803B1 (no) * 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
CZ20032031A3 (cs) * 2001-01-26 2003-12-17 Schering Corporation Farmaceutický prostředek
EP1911462A3 (en) 2001-01-26 2011-11-30 Schering Corporation Compositions comprising a sterol absorption inhibitor
DK1363668T3 (da) * 2001-01-26 2007-11-05 Schering Corp Kombinationer af galdesyrekompleksdanner(e) og sterolabsorptionsinhibitor(er) og behandling af vaskulære indikationer
AU2002247019C1 (en) * 2001-01-26 2017-05-11 Organon Llc Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
AR034204A1 (es) * 2001-01-26 2004-02-04 Schering Corp Composiciones y combinaciones de acido nicotinico y derivados del mismo con inhibidor(es) de la absorcion de los esteroles, y el uso de los mismos para preparar medicamentos para el tratamiento para indicaciones vasculares
KR20080067717A (ko) * 2001-01-26 2008-07-21 쉐링 코포레이션 스테롤 흡수 억제제와 혈액 조절제를 포함하는 혈관 질환의치료 또는 예방용 약제학적 조성물
CZ305202B6 (cs) * 2001-01-26 2015-06-10 Merck Sharp & Dohme Corp. Farmaceutický prostředek
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
ES2275007T3 (es) * 2001-05-25 2007-06-01 Schering Corporation Uso de derivados de azetidinona sustitudos en el tratamiento de la enfermedad de alzeimer.
FR2828487B1 (fr) * 2001-08-09 2005-05-27 Genfit S A Nouveaux composes derives d'acides gras, preparation et utilisations
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
HUP0401501A3 (en) * 2001-09-21 2012-02-28 Schering Corp Treating or preventing vascular inflammation using pharmaceutical compositions containing sterol absorption inhibitor(s)
JP2005504091A (ja) * 2001-09-21 2005-02-10 シェーリング　コーポレイション ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
JP5008258B2 (ja) 2002-06-20 2012-08-22 アイシー・ベック・リミテッド 含硫黄ホスホリピド誘導体
US20040067267A1 (en) * 2002-10-08 2004-04-08 Murthy Pothapragada Suryanarayana Process for preparation of cholesterol lowering compositions from garlic
EP1560579A1 (en) * 2002-11-06 2005-08-10 Schering Corporation Cholesterol absorption inhibitors for the treatment of autoimmune disorders
US7208486B2 (en) * 2003-03-07 2007-04-24 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP2006519869A (ja) 2003-03-07 2006-08-31 シェーリング　コーポレイション 置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用
WO2004081002A1 (en) 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
EP1680189A2 (en) * 2003-11-05 2006-07-19 Schering Corporation Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
CA2554735A1 (en) * 2004-01-30 2005-08-11 Peplin Biolipids Pty Ltd Therapeutic and carrier molecules
AU2005264781B2 (en) * 2004-07-19 2011-07-28 Life Science Nutrition As Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
CA3052449C (en) 2013-03-11 2021-10-19 Jan Remmereit Lipid compositions comprising 5, 11, 14-eicosatrienoic acid and conjugated linoleic acids
WO2014140934A2 (en) 2013-03-11 2014-09-18 Life Science Nutrition As Natural lipids containing non-oxidizable fatty acids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2208533A1 (de) * 1972-02-23 1973-09-27 Kolmar Laboratories Neue alkylthioaether
NL7405744A (en) * 1974-04-29 1975-10-31 Dow Chemical Co Butylphenyl-thioalkane carboxylic acids - as hypocholesterolaemics and antilipaemics from corresp. thiophenols and haloalkane carboxylic acids
DE2515146A1 (de) * 1975-04-08 1976-10-21 Bayer Ag Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2856683A1 (de) * 1978-12-29 1980-07-17 Nattermann A & Cie Entzuendungshemmende und antiatherosklerotisch wirkende arzneimittel
CH661207A5 (en) * 1980-06-30 1987-07-15 Hoerrmann Wilhelm Pharmaceutical composition containing long-chain aldehydes or carboxylic acids

Also Published As

Publication number Publication date
US5093365A (en) 1992-03-03
GB8813012D0 (en) 1988-07-06
EP0345038A2 (en) 1989-12-06
ATE96664T1 (de) 1993-11-15
EP0345038B1 (en) 1993-11-03
ES2059749T3 (es) 1994-11-16
DE68910386T2 (de) 1994-06-09
CA1329550C (en) 1994-05-17
DE68910386D1 (de) 1993-12-09
DK267689D0 (da) 1989-06-01
EP0345038A3 (en) 1991-06-12

Similar Documents

Publication Publication Date Title
DK267689A (da) Ikke-beta-oxiderbare fede syrer analoge med blodcholesterol- og -triglyceridsaenkende evne og praeparater indeholdende saadanne forbindelser
HUT43599A (en) Process for production of derivatives of thiazolidindion and medical compounds containing those
DK139287A (da) Tertiaere hydroxyalkylxanthiner, deres fremstilling og anvendelse som laegemidler
KR900009079A (ko) 비스(3,5-디-tert-부틸-4-히드록시페닐티오)메탄 함유 콜레스테롤 저하제겸 아테롬성 동맥 경화증 치료제
SE8703625D0 (sv) New medical use
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
AU6567086A (en) Compositions and methods for the treatment of bleeding disorders
ZA899673B (en) Pyridinium polymers and their use as cholesterol lowering agents
GR3002618T3 (en) Solutions of oxazaphosphorins with enhanced stability and process for their preparation
DK337589A (da) 3r,s- og 3r-formerne af 3-substuerede 1-(2-aryl -eller heteroarylethyl)piperidin-forbindelser og deres anvendelse til fremstilling af et laegemiddel til behandling af sygdommme forbundet med aendret motilitet og/eller tonus af glatmuskel samt farmaceutiske praeparater indeholdende disse forbindelser
IE882529L (en) Platinum Coordination Compound
DK562488A (da) Farmaceutisk praeparat indeholdende polyminderivater, samt nogle af disse polyaminderivater
DK158950C (da) Substituerede 1,4-dihydropyridinlactoner og laegemiddel indeholdende disse
DK0488928T3 (da) Pharmaceutiske formuleringer, der indeholder en blanding af højere, primære, alifatiske alkoholer, til behandling af hyperc
ATE71092T1 (de) Hydroxybutenolid-derivate, ihre herstellung und ihre verwendung.
PH21450A (en) N-(6-methoxy-5(perfluoroalkyl)-1-naphthoyl)-n-methylglycines and their thionaphthoyl analogs
IL78954A0 (en) Spiro-imidazolidines and pharmaceutical compositions containing them
DK165981C (da) Isoxazolderivater, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser
ATE70182T1 (de) Therapeutische mittel zur behandlung von magengeschwueren.
DK302486A (da) 11-substituerede 5,11-dihydro-6h-pyrido(2,3-b)(1,4)benzodiazepin-6-oner
ATE86498T1 (de) Verminderung des gehaltes an lipoproteine mit geringer dichte in biologischen fluessigkeiten.
HU910437D0 (en) Process for the production of medical preparations for treating apnoea during sleep
NO931752D0 (no) Oktahydronaftalenoksimderivater til inhibering av kolesterolbiosyntese, samt fremgangsmaate til fremstilling og anvendelse derav
AU584098B2 (en) Substituted azabicycloheptanes, the use thereof, pharmaceutical preparations that contain these compounds, and processes for the manufacture of these compounds
FR2558161B1 (fr) 3-alkoxy 2-(n-pyrrolidino) n-furylmethyl ou n-thienylmethyl n-pyridyl propylamines, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment